159 related articles for article (PubMed ID: 35609990)
1. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
2. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease.
Teipel SJ; Fritz HC; Grothe MJ;
Neurology; 2020 Sep; 95(10):e1301-e1311. PubMed ID: 32631924
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
4. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
[TBL] [Abstract][Full Text] [Related]
6. Multi-pathological contributions toward atrophy patterns in the Alzheimer's disease continuum.
Mohanty R; Ferreira D; Westman E
Front Neurosci; 2024; 18():1355695. PubMed ID: 38655107
[TBL] [Abstract][Full Text] [Related]
7. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
[TBL] [Abstract][Full Text] [Related]
8. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
9. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
10. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.
Dawe RJ; Bennett DA; Schneider JA; Arfanakis K
PLoS One; 2011; 6(10):e26286. PubMed ID: 22043314
[TBL] [Abstract][Full Text] [Related]
11. Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.
Kon T; Ichimata S; Di Luca DG; Martinez-Valbuena I; Kim A; Yoshida K; Alruwaita AA; Kleiner G; Strafella AP; Forrest SL; Sato C; Rogaeva E; Fox SH; Lang AE; Kovacs GG
Brain Commun; 2024; 6(3):fcae141. PubMed ID: 38712319
[TBL] [Abstract][Full Text] [Related]
12. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ
J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153
[TBL] [Abstract][Full Text] [Related]
13. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
14. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
[TBL] [Abstract][Full Text] [Related]
15. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
16. Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.
Phillips JS; Robinson JL; Cousins KAQ; Wolk DA; Lee EB; McMillan CT; Trojanowski JQ; Grossman M; Irwin DJ
J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38050082
[TBL] [Abstract][Full Text] [Related]
17. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
[TBL] [Abstract][Full Text] [Related]
18. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology.
Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ;
Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477
[TBL] [Abstract][Full Text] [Related]
19. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
Jellinger KA
J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
[TBL] [Abstract][Full Text] [Related]
20. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
